Blood pressure, atherosclerosis, and albuminuria in 10 113 participants in the Atherosclerosis Risk in Communities study

Journal of Hypertension

Volumn 27, Issue 2, 2009, Pages 397-409

  Hsu, Charles C ^a,d   Brancati, Frederick L ^a   Astor, Brad C ^a   Kao, Wen Hong ^a   Steffes, Michael W ^b   Folsom, Aaron R ^c   Coresh, Josef ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Atherosclerosis; Blood pressure; Community based; Diabetes; Hypertension; Microalbuminuria; Nephropathy

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; INSULIN; LIPID;

ADULT; AGED; ALBUMINURIA; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ARTERY FLOW; CELL DAMAGE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; ENDOTHELIUM CELL; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; BLOOD PRESSURE; COMORBIDITY; CROSS-SECTIONAL STUDY; MIDDLE AGED; MULTIVARIATE ANALYSIS; STATISTICAL MODEL; UNITED STATES; URINE;

ALBUMINURIA; ATHEROSCLEROSIS; BLOOD PRESSURE; COMORBIDITY; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; UNITED STATES;

EID: 63849178953     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32831aede6     Document Type: Article

References (51)

1. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990; 300:297-300.
2. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in noninsulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997; 157:1413-1418.
3. Hallan S, Astor B, Romundstad S, Aasarod K, Kvenild K, Coresh J. Association of kidney function and albuminuria with cardiovascular mortality in older vs. younger individuals: The HUNT II Study. Arch Intern Med 2007; 167:2490-2496.
4. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992; 41:736-741.
5. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. Br Med J 1996; 313:779-784.
6. Valmadrid CT, Klein R, Moss SE, Klein BE. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 2000; 160:1093-1100.
7. Chavers BM, Bilous RW, Ellis EN, Steffes MW, Mauer SM. Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med 1989; 320:966-970.
8. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulindependent patients. N Engl J Med 1984; 311:89-93.
9. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulindependent diabetes mellitus. Lancet 1982; 1:1430-1432.
10. Cohn JN, Quyyumi AA, Hollenberg NK, Jamerson KA. Surrogate markers for cardiovascular disease: functional markers. Circulation 2004; 109 (25 Suppl 1):IV31-IV46.
11. Kramer H, Jacobs DR Jr, Bild D, Post W, Saad MF, Detrano R, et al. Urine albumin excretion and subclinical cardiovascular disease. The Multi-Ethnic Study of Atherosclerosis. Hypertension 2005; 46:38-43.
12. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339:1448-1456.
13. Yokoyama H, Aoki T, Imahori M, Kuramitsu M. Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity. Kidney Int 2004; 66:448-454.
14. USRDS 2001 Annual Data Report. Bethesday, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2001.
15. Diamond JR, Karnovsky MJ. Focal and segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int 1988; 33:917-924.
16. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334:13-18.
17. Ma KW, Greene EL, Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 1992; 19:505-513.
18. Chambless LE, Folsom AR, Davis V, Sharrett R, Heiss G, Sorlie P, et al. Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987-1998. Am J Epidemiol 2002; 155:38-47.
19. Agewall S, Bjorn F. Microalbuminuria and intima-media thickness of the carotid artery in clinically healthy men. Atherosclerosis 2002; 164:161-166.
20. Mykkanen L, Zaccaro DJ, O'Leary DH, Howard G, Robbins DC, Haffner SM. Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS). Stroke 1997; 28:1710-1716.
21. McDonald SP, Maguire GP, Duarte N, Wang XL, Hoy WE. Carotid intimamedia thickness, cardiovascular risk factors and albuminuria in a remote Australian Aboriginal community. Atherosclerosis 2004; 177:423-431.
22. Furtner M, Kiechl S, Mair A, Seppi K, Weger S, Oberhollenzer F, et al. Urinary albumin excretion is independently associated with carotid and femoral artery atherosclerosis in the general population. Eur Heart J 2005; 26:279-287.
23. Knight EL, Kramer HM, Curhan GC. High-normal blood pressure and microalbuminuria. Am J Kidney Dis 2003; 41:588-595.
24. Murtaugh MA, Jacobs DR Jr, Yu X, Gross MD, Steffes M. Correlates of urinary albumin excretion in young adult blacks and whites: the Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol 2003; 158:676-686.
25. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989; 129:687-702.
26. Shahar E, Folsom AR, Jackson R. The effect of nonresponse on prevalence estimates for a referent population: insights from a population-based cohort study. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Ann Epidemiol 1996; 6:498-506.
27. National Heart Lung and Blood Institute. ARIC Manual of Operation: no. 1, general description and study management; no 2, cohort component procedures; no 3, surveillance component procedures; no. 4, pulmonary function assessment; no. 5, electrocardiography; no. 6, ultrasound assessment; no. 7, blood collection and processing; no. 8, lipid and lipoprotein determinations; no. 9. hemostasis determinations; no. 10, clinical chemistry determinations; no. 11, sitting blood pressure and postural changes in blood pressure and heart rate; no. 12, quality assurance. ARIC Coordinating Center, School of Public Health, University of North Carolina, Suite 203, NCNB Plaza, 137 E. Franklin St., Chapel Hill, NC 27514; 1987.
28. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157:2413-2446.
29. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 Suppl 1):S1-S266.
30. Levey AS, Greene T, Kusek JW, Beck GJ, and MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11:155A; [abstrA0828].
31. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991; 134:250-256
32. Sharrett AR, Coady SA, Folsom AR, Couper DJ, Heiss G. Smoking and diabetes differ in their associations with subclinical atherosclerosis and coronary heart disease-the ARIC Study. Atherosclerosis 2004; 172:143-149.
33. Espeland MA, Byington RP, Hire D, Davis VG, Hartwell T, Probstfield J. Analysis strategies for serial multivariate ultrasonographic data that are incomplete. Stat Med 1992; 11:1041-1056.
34. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, et al. Nephropathy in diabetes. Diabetes Care 2004; 27 (Suppl 1): S79-S83.
35. Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, Parving HH, et al. Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis 2003; 42:617-622.
36. Levey ASC Jeal. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2, Suppl 1).
37. Cirillo M, Senigalliesi L, Laurenzi M, Alfieri R, Stamler J, Stamler R, et al. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study. Arch Intern Med 1998; 158:1933-1939.
38. Goetz FC, Jacobs DR Jr, Chavers B, Roel J, Yelle M, Sprafka JM. Risk factors for kidney damage in the adult population of Wadena, Minnesota. A prospective study. Am J Epidemiol 1997; 145:91-102.
39. Martinez MA, Moreno A, Aguirre DC, Cabrera R, Rocha R, Torre A, et al. Frequency and determinants of microalbuminuria in mild hypertension: a primary-care-based study. J Hypertens 2001; 19:319-326.
40. Metcalf P, Baker J, Scott A, Wild C, Scragg R, Dryson E. Albuminuria in people at least 40 years old: effect of obesity, hypertension, and hyperlipidemia. Clin Chem 1992; 38:1802-1808.
41. Palatini P, Graniero GR, Mormino P, Mattarei M, Sanzuol F, Cignacco GB, et al. Prevalence and clinical correlates of microalbuminuria in stage I hypertension. Results from the Hypertension and Ambulatory Recording Venetia Study (HARVEST Study). Am J Hypertens 1996; 9 (4 Pt 1):334-341.
42. Parving HH, Mogensen CE, Jensen HA, Evrin PE. Increased urinary albumin-excretion rate in benign essential hypertension. Lancet 1974; 1:1190-1192.
43. Pontremoli R, Sofia A, Ravera M, Nicolella C, Viazzi F, Tirotta A, et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: a Genoa investigation of complications. Hypertension 1997; 30:1135-1143.
44. Winocour PH, Harland JO, Millar JP, Laker MF, Alberti KG. Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis 1992; 93:71-81.
45. Agewall S, Wikstrand J, Ljungman S, Fagerberg B. Urinary albumin excretion is associated with the intima-media thickness of the carotid artery in hypertensive males with noninsulin-dependent diabetes mellitus. J Hypertens 1995; 13:463-469.
46. Bigazzi R, Bianchi S, Nenci R, Baldari D, Baldari G, Campese VM. Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Hum Hypertens 1995; 9:827-833.
47. Pedrinelli R, Dell'Omo G, Penno G, Bandinelli S, Giannini D, Balbarini A, et al. Dissociation between microalbuminuria and common carotid thickness in essential hypertensive men. J Hum Hypertens 2000; 14:831-835.
48. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41:1-12.
49. Verhave JC, Gansevoort RT, Hillege HL, Bakker SJ, De ZD, de Jong PE. An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. Kidney Int Suppl 2004; 92:S18-S21.
50. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140:167-174.
51. Rowley K, O'Dea K, Best JD. Association of albuminuria and the metabolic syndrome. Curr Diab Rep 2003; 3:80-86.